CIPLA LINEZOLID linezolid 600 mg film-coated tablet bottle

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

linezolid, Quantity: 600 mg

Inapatikana kutoka:

Cipla Australia Pty Ltd

INN (Jina la Kimataifa):

Linezolid

Dawa fomu:

Tablet, film coated

Tungo:

Excipient Ingredients: magnesium stearate; hyprolose; sodium starch glycollate type A; microcrystalline cellulose; maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

20, 100

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

CIPLA LINEZOLID is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,CIPLA LINEZOLID is active against Gram-positive bacteria only. ,CIPLA LINEZOLID has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.

Bidhaa muhtasari:

Visual Identification: White to off-white, oval shaped, biconvex, film-coated tablets, debossed on one side "CL".; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2017-01-24